Diet and Nutrition: For People Living with Hepatitis C

Diet and Nutrition: For People Living with Hepatitis C
ISBN-10
1500186732
ISBN-13
9781500186739
Category
Medical
Pages
28
Language
English
Published
2014-06-13
Publisher
CreateSpace
Authors
National Library of Medicine, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infect

Description

Diet and Nutrition - For People Living with Hepatitis C - How Diet Affects the Liver. National Institute of Allergy and Infectious Diseases - National Library of Medicine. Understanding Hepatitis C and Diet. If you are diagnosed with hepatitis C infection, your healthcare provider will examine you for liver disease and prescribe medicine to get rid of the virus. Two medicines are used to treat hepatitis C: interferon and ribavirin. Most health experts advise using both drugs together. The response to treatment varies from person to person. About 15 to 25 percent of those infected with hepatitis C will recover completely. Because other hepatitis viruses and alcohol use are associated with faster progression of the disease, health experts advise people with hepatitis C to avoid drinking alcohol and to be vaccinated against hepatitis A and hepatitis B viruses. Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer, or life-threatening esophageal and gastric varices. HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, and transfusions. An estimated 150-200 million people worldwide are infected with hepatitis C. The existence of hepatitis C (originally identifiable only as a type of non-A non-B hepatitis) was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees. The virus persists in the liver in about 85% of those infected. This chronic infection can be treated with medication: the standard therapy is a combination of peginterferon and ribavirin, with either boceprevir or telaprevir added in some cases. Overall, 50-80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation. No vaccine against hepatitis C is available.

Similar books